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Abstract
Background: Radon is the second risk factor for lung cancer after tobacco consumption and therefore it is necessary 
to know the burden of disease due to its exposure. The objective of this study is to estimate radon-attributable lung 
cancer mortality in Galicia, a high emission area located at the Northwest Spain.
Methods: A prevalence-based attribution method was applied. Prevalence of tobacco use and radon exposure were 
obtained from a previously published study of the same area. Attributable mortality was calculated for each of six 
possible risk categories, based on radon exposure and smoking status. Two scenarios were used, with 37 Bq/m3 and 
148 Bq/m3 as the respective radon exposure thresholds. As the observed mortality we used lung cancer mortality for 
2001 from the Galician mortality registry.
Results: Mortality exclusively attributable to radon exposure ranged from 3% to 5% for both exposure thresholds, 
respectively. Attributable mortality to combined exposure to radon and smoking stood at around 22% for exposures 
above 148 Bq/m3. Applying the United States Environmental Protection Agency (EPA) action level, radon has a role in 
25% of all lung cancers.
Conclusions: Although the estimates have been derived from a study with a relatively limited sample size, these 
results highlight the importance of radon exposure as a cause of lung cancer and its effect in terms of disease burden. 
Radon mitigation activities in the study area must therefore be enforced.
Background
Lung cancer is a serious Public Health problem. Tobacco
is the main risk factor and radon exposure is the second
one [1]. Radon is a colorless, odorless and tasteless gas
with a half-life of 3.8 days. On decaying, its short-lived
decay progeny emits radioactive alpha particles that
cause lung cancer [2,3]. The relationship between this gas
and lung cancer was first established in miners [4,5]. Epi-
demiologic studies observed later that persons exposed to
elevated radon levels in their homes had a higher risk of
developing lung cancer [3]. Radon gas has been declared
a human carcinogen by the International Agency for
Research on Cancer (IARC) [6]. These findings have led
the United States Environmental Protection Agency
(EPA)[7] and the European Commission[8] to set action
levels at 148 Bq/m3 and 200 Bq/m3, respectively, advising
implementation of radon reduction measures at any
home exceeding these thresholds. Accumulated evidence
on the hazard posed by radon exposure has spurred many
European countries, the USA and Canada to elaborate
maps showing which geographic regions have elevated
radon levels. WHO is also leading the International
Radon Project, which has among its objectives to esti-
mate the global burden of disease caused by radon expo-
sure [9].
Galicia, the study area, has the highest indoor radon
concentrations throughout Spain, due to the granitic
nature of the subsoil and also because many homes in the
countryside are built with granite. Different studies have
shown that approximately 20% of all dwellings exceed the
EPA action level [10,11].
In the context of decision making it is essential to know,
albeit approximately, the impact that a given risk factor
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Page 2 of 6has on the mortality of a population [12]. Since atribut-
able mortality is a good public health indicator that
allows knowing the burden of disease caused by radon in
lung cancer, the objective of this investigation is to calcu-
late radon attributable mortality for Galicia, the highest
risk area in Spain.
Methods
Setting
Galicia is a region in the Northwest of Spain, with a popu-
lation of approximately 2,700,000 and an area of 28,000
sq. km. It is bordered to the North and West by the Atlan-
tic Ocean, to the East by the remainder of mainland
Spain, and to the South by Portugal. Former studies have
indicated that it is an area with high radon emission levels
[10,11,13].
Method used and data sources
We used a method previously employed for the estima-
tion of attributable deaths related to tobacco use [14] and
environmental tobacco smoke [15].
Attributable lung cancer deaths (AM) are calculated as
follows:
AM = OM × PAF, where OM (Observed Mortality) is
the number of lung cancer deaths (of those 35 years and
older) that occurred in Galicia in 2001 and PAF is the
population-attributable fraction. PAF is a function of the
exposure prevalence among cases (p) and Odds Ratio [16-
18], and is denoted as . For the present
study p is the proportion of subjects among lung cancer
cases exposed to each of the risk factors analyzed, radon
and tobacco. Since we consider two scenarios of radon
exposure, 37 and 148 Bq/m3, and three categories for
tobacco smoking (never smokers, ex-smokers and cur-
rent smokers), six prevalences and six ORs are applied for
each scenario. An ex-smoker was defined as any individ-
ual who had smoked a minimum of one cigarette per day
but stopped at least one year before the interview for the
study and a current smoker as an individual who has
being smoking at least one cigarette per day in the last
year. Those who quitted less than one year before the
information was collected were classified as current
smokers.
Prevalences and Odds Ratios were obtained from a
population-based case-control study (with controls ran-
domly selected) conducted in Galicia over the period
1992-1994 [10]. The objective of this study was to assess
the relationship between radon exposure and lung cancer
and included 163 cases and 241 controls (404 houses
measured).
The observed mortality due to lung cancer in Galicia
was obtained from the Galician Mortality Registry.
The 3 categories of smoking status were never-smok-
ers, ex-smokers and current smokers. Risks were
obtained using the SPSS 12.0 statistical package by means
of unconditional logistic regression, where the dependent
variable was the case or control status and the indepen-
dent variables were the different categories of exposure to
radon and smoking. As variables of adjustment, we con-
sidered age, sex, and family history of cancer.
Results
The characteristics of the study subjects used to calculate
radon attributable mortality are shown in Table 1. The
geometric mean of radon exposure (geometric means
were calculated because radon follows a log-normal dis-
tribution) was 66.4 Bq/m3 for controls; and 75.4 Bq/m3
for cases. The percentage of homes in the study area with
concentrations above 148 Bq/m3 (action level in the USA)
is 19.4% which ranks Galicia as a risk region in terms of
residential exposure. There were many more smokers
among cases than among controls, and the number of
packets smoked over a lifetime was also greater in these.
Exposure prevalences to tobacco and radon are shown
in Table 2. The prevalence of radon exposure is higher
above the 37 Bq/m3 threshold and the opposite happens
for the 148 Bq/m3 one. Something similar occurs with
smoking exposure for both thresholds. Odds Ratios are
slightly higher when tobacco and radon exposure are
combined compared with ORs calculated only for smok-
ers.
Table 3 shows the estimated attributable mortality in
percentage terms and absolute numbers. In both scenar-
ios, mortality attributed to causes other than smoking
and radon ranged from 6.5% to 8%. Mortality exclusively
attributable to smoking was 67% for those exposed to
over 148 Bq/m3 whereas mortality exclusively attributable
to radon was 4.5% and 3.3% for subjects exposed to over
37 Bq/m3 and 148 Bq/m3, respectively. In the 148 Bq/m3
scenario it can be observed that radon exposure partici-
pates in 25% of all lung cancer deaths and that the 22% of
all deaths can be attributed to the simultaneous exposure
to radon and smoking. These figures are much higher for
the 37 Bq/m3 scenario since most of the population is
exposed to higher radon concentrations.
Discussion
This is the first study in Spain and one of the few under-
taken in Europe that estimates lung cancer mortality
attributable to radon. The main result is that, while mor-
tality exclusively attributable to radon is low, i.e., in the
order of 3%-5%, mortality attributable to the combined
exposure to radon and smoking is far higher, 22% for ever
smokers exposed to over 148 Bq/m3. The attributable
mortality to individuals exposed to over 37 Bq/m3 is
PAF p OR= −( )1
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Page 3 of 6higher, and results point out that a high number of lung
cancer deaths could be prevented with radon mitigation
measures along with smoking cessation.
These results are in line with those reported by other
studies. A study conducted in West Germany [19]
observed that, with a geometric mean radon concentra-
tion of 40 Bq/m3, the attributable fraction ranged from
7% to 22% for male non-smokers and from 5% to 7% for
smokers, suggesting that radon might be more important
in relative terms in non smokers compared with smokers.
The authors also estimated that 7% of all lung cancer
deaths could be attributed to radon. In 1987, the German
Radiation Protection Commission estimated that 4%-12%
of lung cancer mortality could be due to inhalation of res-
idential radon [20]. Two studies have been recently pub-
lished estimating radon attributable mortality for lung
cancer in England and France. In England around 3.3% of
lung cancer cases are attributable to radon (with a mean
radon concentration of 21 Bq/m3)[21] and the French
study showed that radon causes from 2 to 12% of all lung
cancer deaths [22].
In the opinion of Lubin and Boice [23], 14% of lung can-
cer deaths are attributable to radon (with "exposed"
defined as being from 2 Bq/m3 upwards). Eliminating
exposures above 296 Bq/m3 and 148 Bq/m3 would pre-
vent only 2% and 5% of lung cancer cases, respectively.
Approximately 80% of deaths attributed to radon occur
among smokers. This attributable mortality is very simi-
lar to that calculated by Puskin and Yang [24]. Another
study, conducted by Leenhouts and cols [25] indicates
that higher exposure to radon among the Swedish versus
the Dutch population is reflected in the percentage of
lung cancer attributable to radon, i.e., 25% versus less
than 10%. Among males, the percentage exclusively
attributable to radon is 2% in Holland and 17% in Sweden
(for women these percentages are 6% and 24%, respec-
tively). In both countries, radon and/or tobacco account
for 80% of all lung cancer deaths. These differences high-
light the fact that calculating attributable radon mortality
to a whole country with large differences in residential
radon exposure would be rather misleading since radon is
Table 1: Description of the study population used to obtain the risks and prevalences for the attribution model.
Casesa Controlsa
SEX
Males (%) 151 (92.6) 219 (92.9)
AGE (years)
Median (SD) 65.7 (10.5) 57.7 (12.5)
EXPOSURE TO RADONb
Geometric mean (GSD) 75.4 (2.4) 66.4 (3.0)
Median (pct 25, 75) 66.6 (40.7, 144.5) 51.8 (29.6, 118.4)
Number of homes (individuals) with concentrations above 37 Bq/m3 (%) 125 (78.6) 155 (65.4)
Number of homes (individuals) with concentrations above 148 Bq/m3 (%) 42 (26.4) 46 (19.4)
TOBACCO CONSUMPTION
Never smokers (%) 14 (8.6) 98 (40.7)
Ex-smokers (%) 75 (46.0) 57 (23.7)
Current smokers (%) 74 (45.4) 86 (35.7)
Meanc (SD) 24.2 (16.9) 7.1 (9.9)
Medianc (pct 25,75) 21.9 (14.6, 35.3) 7.1 (0.0, 10.9)
PRESENCE OF RADON MONITORING DEVICE
Days (mean, SD) 155.3 (31.1) 150.9 (55.3)
aThe total number of cases and controls was 404 individuals
bAll radon measurements were adjusted by seasonality
cCalculated for current smokers. Thousands of packets smoked over a lifetime.
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what happens in Spain.
It is normal for attributable mortality above 37 Bq/m3
to be higher than that above 148 Bq/m3, since the number
of exposed subjects is higher. The figure of 37 Bq/m3 was
chosen because earlier studies in the same area had
already indicated a significative risk of lung cancer as
from this radon level, along with evidence of an interac-
tion with smoking [10]. The 148 Bq/m3 threshold was
chosen because it is the designated EPA action level. It is
also very important to keep in mind that although having
defined, for practical reasons in one scenario, those indi-
viduals under 148 Bq/m3 as non exposed, they are still
subject to a considerable risk of lung cancer due to radon
exposure. Choosing two exposure levels allows for com-
parison of attributable mortalities and also highlights the
fact that there is no safe radon-exposure level, as shown
by the 4.5% of deaths among non-smokers exposed to
over 37 Bq/m3. When radon concentration is higher than
148 Bq/m3, up to 25% of lung cancer deaths (among
smokers, ex-smokers, and non-smokers alike) could
probably be prevented with radon reduction interven-
tions, which translates as 332 lung cancer deaths in the
study area, almost one per day in 2001. Nevertheless,
Denman and cols [26] have indicated that, even though
radon affected areas have been defined by the National
Radiological Protection Board as those with over 1% of
homes above the action level, radon mitigation activities
could only be cost-effective in areas with 5% of homes
above 200 Bq/m3. At all events, Galicia more than fulfills
this requirement, with 17.7% of homes exceeding 200 Bq/
m3.
The interaction that exists between radon and tobacco
use (seen as additive by some and multiplicative by oth-
ers) [27-29] has been used by health authorities as a
means to persuade people to quit smoking, and the data
yielded by this study seem to support this practice. Nev-
ertheless, the fact that most of the Galician population
have no idea about radon and its effects, does not con-
tribute to address the problem posed by radon exposure.
Counteracting this ignorance is the recent WHO initia-
tive [9], aimed at raising the awareness of governments,
authorities and, ultimately, citizens, to radon and the
related health risk, so that authorities take (and citizens
Table 2: Prevalences and odds ratiosa used for estimating attributable mortality.b
37 Bq/m3 148 Bq/m3
n Prevalence OR and 95% CI n Prevalence OR and 95% CI
Non-exposed non-smokers 2 1.3% 1.00 8 5% 1.00
Non-exposed ex-smokers 23 14.5% 34.14 (5.81-200.42) 63 39.6% 48.65 (13.01-181.91)
Non-exposed smokers 9 5.7% 14.38 (2.28-90.55) 46 28.9% 29.95 (8.12-110.48)
Exposed non-smokers 12 7.4% 2.50 (0.47-13.46) 6 3.9% 7.39 (1.68-32.56)
Exposed ex-smokers 51 32.1% 44.88 (8.13-247.63) 11 6.9% 24.07 (5.24-110.52)
Exposed smokers 62 39.0% 43.23 (7.96-234.92) 25 15.7% 53.41 (12.88-221.49)
a Adjusted for sex, age, and family history of cancer.
b Source: Barros-Dios JM, Barreiro Carracedo MA, Ruano-Ravina A, Figueiras A. Exposure to residential radon and lung cancer risk in Spain: a 
population-based case-control study. Am J Epidemiol. 2002. 156 (6): 548-55.
Table 3: Percentage of lung cancer mortality in Galicia attributable to exposure to radon and smoking
37 Bq/m3 148 Bq/m3
Attributable deaths Attributable number Attributable deaths Attributable number
Non-exposed never-smokers 6.66% 87 7.98% 105
Non-exposed ex-smokers 14.07% 185 38.78% 509
Non-exposed current smokers 5.30% 70 27.93% 367
Exposed never-smokers 4.50% 59 3.29% 43
Exposed ex-smokers 31.38% 412 6.61% 87
Exposed current smokers 38.09% 500 15.41% 202
Total 100% 1313 100% 1313
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posed is the inclusion of radon mitigation guidelines in
building technical regulations, something that is simple
to implement where new buildings are being constructed
but more difficult in the case of existing buildings. Many
countries have already introduced mandatory guidelines
to prevent or reduce radon entry in buildings. Galicia has
passed a law in January 2009 compelling all new dwellings
to be protected against radon entry [30].
This study has a number of strengths and one of them is
that it is the first to estimate radon-attributable lung can-
cer mortality in Spain. Another advantage is that the data
obtained for constructing the attribution model came
from a study performed in the same area to which such
mortality is sought to be attributed and where controls
were randomly chosen from the census and the risks
adjusted for sex, age, and family history of cancer.
Although uncertainty is always present in epidemiologic
research and is even higher in attribution studies, we do
not believe that this might be a problem with our calcula-
tions because the parameters used in the attribution for-
mula (prevalences and ORs) have been obtained using
reliable methods and are representative of the study area.
Our study also suffers from limitations. Two are related
to the case-control study used to estimate prevalence of
exposure. The number of cases was low and also the sam-
ple size; nevertheless, other cross-sectional studies
undertaken in Galicia support the estimated smoking
prevalence [31]. Another limitation is that it assumed
uniform exposure to a given radon concentration
throughout lifetime, something that is not true because
people are likely to move home. Other studies take this
mobility into account but while mobility is an important
factor in other countries [32], in Galicia individuals tend
to remain in the same home for many years. Indeed, in
the study from which the data came, two thirds of all sub-
jects had lived for over 20 years in the dwellings where
radon was measured, with no significant differences
between cases and controls [10]. The fact that the
method assumes lung cancer incidence to be equivalent
to mortality could be considered as a problem, but this
assumption is easy to make for this particular cancer
owing to its high lethality and the impossibility of taking
into account the length of time during which ex-smokers
have not smoked. A further possible disadvantage might
be that the method used is different to that employed by
other studies or the BEIR VI model [2] and thus hinders
comparability of results, but in our opinion the used
method is the best suited to the available data, due to its
applicability to the studied region. One model could have
been used to estimate radon attributable deaths using two
cut-points on 37 Bq/m3 and on 148 Bq/m3. This was not
done since for each of the three exposure categories cre-
ated three Odds Ratios would be needed (never smokers,
ex-smokers and current smokers) having finally nine ORs
and nine prevalences. The small sample size of our study
would therefore render inaccurate estimations when
using many categories. The only difference between the
two models is the radon cut-points, being the other vari-
ables included exactly the same.
Conclusions
Two conclusions can be drawn from the results of this
study, although these are limited due to the low sample
size. First, mortality exclusively attributable to the effect
of radon is -as expected- quite low, between 3%-5%. Sec-
ond, mortality attributable to combined exposure to
radon and smoking is considerably high in Galicia,
around 22% (with radon participating in 25% of all lung
cancer deaths), confirming once again the problem posed
by this gas in this north-western region of Spain. This is
an important health problem affecting the Galician popu-
lation and it calls for a deep involvement of national and
regional authorities.
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